Trial Search
Current Search Criteria:
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
PHASE2Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
Study of ONO-4578 and XELOX/FOLFOX Plus Bevacizumab in Colorectal Cancer
PHASE1To evaluate the tolerability and safety of combination of ONO-4578 and ONO-...
Status
Active Not Recruiting
Location
National Cancer Center Hospital East
Start Date
2021-01-13
Trial ID
NCT06547385
Treatments Being Tested
LEAC-102 for Advanced Colorectal Cancer
PHASE1A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT02826837
Treatments Being Tested
DCE-MRI PET Bevacizumab Study in Rectal Cancer
PHASE2This study will determine the following: the response rate (including patho...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01426074
Treatments Being Tested
Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer
PHASE4The aim of this work is to assess the antitumor effect of Pentoxiphylline i...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06115174
Treatments Being Tested
Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
PHASE2The dual immunotherapy regimen significantly outperformed previous chemothe...
Status
Recruiting
Location
Zhongshan hosptial, Fudan University
Start Date
2024-01-01
Trial ID
NCT06218810
Treatments Being Tested
Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer
PHASE4This study will be a prospective one conducted within a time frame between ...
Status
Completed
Location
Baghdad Medical city
Start Date
2022-09-01
Trial ID
NCT06843954
Treatments Being Tested
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
PHASE2To improve the survival in patients with microsatellite stable metastatic c...
Status
Recruiting
Location
Fudan University
Start Date
2024-03-01
Trial ID
NCT06841159
Treatments Being Tested
FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
PHASE2This is a Phase II open-label study to determine the anti-tumor efficacy an...
Status
Completed
Location
Medical Oncology & Hematology PC
Start Date
2008-05
Trial ID
NCT00673673
Treatments Being Tested
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
PHASE1This study is designed to evaluate the efficacy and safety of sintilimab-be...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-30
Trial ID
NCT07522411
Treatments Being Tested